SE444172B - Forfarande for framstellning av farmaceutiskt godtagbara syraadditionssalter av 1-n-etylsisomicin - Google Patents

Forfarande for framstellning av farmaceutiskt godtagbara syraadditionssalter av 1-n-etylsisomicin

Info

Publication number: SE444172B
Authority: SE; Sweden
Prior art keywords: acid addition; addition salts; ethylsisomicine; procedure; acceptable acid
Prior art date: 1973-08-06

Application number

SE7805684A

Other languages

English (en)

Swedish (sv)

Other versions

SE7805684L (sv

Inventor

M J Weinstein

P J L Daniels

G H Wagman

R Testa

A K Mallams

J J Wright

T L Nagabhushan

Original Assignee

Scherico Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1973-08-06

Filing date

1978-05-17

Publication date

1986-03-24

1978-05-17 Application filed by Scherico Ltd filed Critical Scherico Ltd

1978-05-17 Publication of SE7805684L publication Critical patent/SE7805684L/xx

1986-03-24 Publication of SE444172B publication Critical patent/SE444172B/sv

Links

239000002253 acid Substances 0.000 title claims description 8
238000000034 method Methods 0.000 title claims description 5
150000003839 salts Chemical class 0.000 claims description 7
150000001875 compounds Chemical class 0.000 claims description 6
239000012458 free base Substances 0.000 claims description 2
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 10
ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 description 6
URWAJWIAIPFPJE-UHFFFAOYSA-N Rickamicin Natural products O1CC(O)(C)C(NC)C(O)C1OC1C(O)C(OC2C(CC=C(CN)O2)N)C(N)CC1N URWAJWIAIPFPJE-UHFFFAOYSA-N 0.000 description 5
URWAJWIAIPFPJE-YFMIWBNJSA-N sisomycin Chemical compound O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC=C(CN)O2)N)[C@@H](N)C[C@H]1N URWAJWIAIPFPJE-YFMIWBNJSA-N 0.000 description 5
241000894006 Bacteria Species 0.000 description 4
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
229930192786 Sisomicin Natural products 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
229960005456 sisomicin Drugs 0.000 description 3
238000003756 stirring Methods 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
239000000908 ammonium hydroxide Substances 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
238000004587 chromatography analysis Methods 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000003456 ion exchange resin Substances 0.000 description 2
229920003303 ion-exchange polymer Polymers 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
241000588769 Proteus <enterobacteria> Species 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
229920001429 chelating resin Polymers 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
238000006200 ethylation reaction Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
239000011976 maleic acid Substances 0.000 description 1
238000001819 mass spectrum Methods 0.000 description 1
208000004396 mastitis Diseases 0.000 description 1
AGFWIZQEWFGATK-UNZHCMSXSA-N netilmicin sulfate Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N.O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](NC)[C@@](C)(O)CO1)O)NCC)[C@H]1OC(CN)=CC[C@H]1N AGFWIZQEWFGATK-UNZHCMSXSA-N 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
229910017604 nitric acid Inorganic materials 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
239000003495 polar organic solvent Substances 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
239000007787 solid Substances 0.000 description 1
241000894007 species Species 0.000 description 1
239000007858 starting material Substances 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
- C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

SE7805684A 1973-08-06 1978-05-17 Forfarande for framstellning av farmaceutiskt godtagbara syraadditionssalter av 1-n-etylsisomicin SE444172B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US38575173A	1973-08-06	1973-08-06
US45260074A	1974-03-19	1974-03-19

Publications (2)

Publication Number	Publication Date
SE7805684L SE7805684L (sv)	1978-05-17
SE444172B true SE444172B (sv)	1986-03-24

Family

ID=27011126

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7805684A SE444172B (sv)	1973-08-06	1978-05-17	Forfarande for framstellning av farmaceutiskt godtagbara syraadditionssalter av 1-n-etylsisomicin

Country Status (3)

Country	Link
DK (1)	DK150202C (da)
FR (1)	FR2305190A1 (da)
SE (1)	SE444172B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4298690A (en) *	1977-05-19	1981-11-03	Kyowa Hakko Kogyo Co., Ltd.	Antibiotics XK-62-3 and XK-62-4 and process for production thereof
DE2924659A1 (de) *	1979-06-19	1981-01-22	Bayer Ag	Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel

1976
- 1976-05-10 FR FR7613947A patent/FR2305190A1/fr active Granted
1978
- 1978-05-17 SE SE7805684A patent/SE444172B/sv not_active IP Right Cessation
1979
- 1979-02-08 DK DK052779A patent/DK150202C/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK150202C (da)	1987-06-22
DK150202B (da)	1987-01-05
DK52779A (da)	1979-02-08
FR2305190A1 (fr)	1976-10-22
SE7805684L (sv)	1978-05-17
FR2305190B1 (da)	1980-12-05

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 7805684-3

Effective date: 19940910

Format of ref document f/p: F

Publication	Publication Date	Title
Kavanagh et al.	1952	Antibiotic Substances from Basidiomycetes: IX. Drosophila Subtarata.(Batsch Ex Fr.) Quel.
JPS5649382A (en)	1981-05-02	6-fluoro-7-cyclic amino-1,8-naphthylidine derivative and its salt
JPS582960B2 (ja)	1983-01-19	新規なプソイドサッカライド類の製造方法
US3856969A (en)	1974-12-24	Kasugamycin as a plant disease preventive agent
CH501011A (de)	1970-12-31	Verfahren zur Herstellung von 7-(a-Aminophenylacetamino)-3-methyl- 3-cephem-4-carbonsäure-Derivaten
DE2437160B2 (de)	1979-01-04	1-N-Äthylsisomicin und Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CA2077562A1 (en)	1993-03-08	Diastereomers of 1-(isopropoxycarbonyloxy) ethyl 3-cephem-4-carboxylate and processes for their preparation
SE444172B (sv)	1986-03-24	Forfarande for framstellning av farmaceutiskt godtagbara syraadditionssalter av 1-n-etylsisomicin
DE1948943C2 (de)	1982-09-23	Arzneimittel, enthaltend D-&alpha;-Sulfobenzylpenicillin
US3880828A (en)	1975-04-29	Antibiotics 66-40B and 66-40D from micromonospora inyoensis
DE2203653B2 (de)	1974-12-19	3-Carbamoyloxymethyl-7-(2-thienylacetamido)-3-cephem-4-carbonsäure und deren Salze, Verfahren zur Herstellung dieser Verbindungen und solche Verbindungen enthaltende Arzneimittel
AT397090B (de)	1994-01-25	Verfahren zur herstellung von neuen carbapenemderivaten
CN104530082A (zh)	2015-04-22	头孢硫脒化合物
Dymicky et al.	1977	Inhibition of clostridium botulinum by 5-nitrothiazoles
FI62843C (fi)	1983-03-10	Foerfarande foer framstaellning av ett syraadditionssalt av 1--etylsisomicin
GB1594780A (en)	1981-08-05	1-n-(aminoalkenesulfonyl)derivative of aminoglycosidic antibiotic and process for preparation thereof
US20080221076A1 (en)	2008-09-11	Crystalline Sodium Salt of Cephalosporin Antibiotic
CN1112923A (zh)	1995-12-06	1-{[2-(环丙基羰基)-4-氟苯基]氨磺酰}-3-(4，6-二甲氧基-2-嘧啶基)脲及其除草方法
DE1795508C (de)	1973-01-25	6-(alpha- Aminoacylamino)-penicillansäurederivate. Ausscheidung aus: 144 5419
NO881644D0 (no)	1988-04-15	Fremgangsmaate for fremstilling av thiadiazolylacetamid cefem-derivater.
US4243801A (en)	1981-01-06	6"-Amino derivatives of 4-0-aminoglycosyl-6-0-garosaminyl-1,3-diaminocyclitols
PL80679B1 (da)	1975-08-30
CH586708A5 (da)	1977-04-15
GB2138822A (en)	1984-10-31	Actaplanin antibiotics
RU2672472C1 (ru)	2018-11-15	Замещенные аминобензопентатиепины в качестве антимикробных средств